353 related articles for article (PubMed ID: 19047896)
1. Clinical, pathologic, and molecular features of early-onset colorectal carcinoma.
Yantiss RK; Goodarzi M; Zhou XK; Rennert H; Pirog EC; Banner BF; Chen YT
Am J Surg Pathol; 2009 Apr; 33(4):572-82. PubMed ID: 19047896
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
[TBL] [Abstract][Full Text] [Related]
3. Filiform serrated adenomas: a clinicopathologic and immunophenotypic study of 18 cases.
Yantiss RK; Oh KY; Chen YT; Redston M; Odze RD
Am J Surg Pathol; 2007 Aug; 31(8):1238-45. PubMed ID: 17667549
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal carcinomas.
Furlan D; Sahnane N; Carnevali I; Cerutti R; Bertoni F; Kwee I; Uccella S; Bertolini V; Chiaravalli AM; Capella C
Hum Pathol; 2008 Oct; 39(10):1483-94. PubMed ID: 18619649
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma.
Wang WS; Chen PM; Chiou TJ; Liu JH; Lin JK; Lin TC; Wang HS; Su Y
Clin Cancer Res; 2007 Jun; 13(12):3597-604. PubMed ID: 17575224
[TBL] [Abstract][Full Text] [Related]
7. Colorectal carcinoma: a retrospective, descriptive study of age, gender, subsite, stage, and differentiation in Iran from 1995 to 2001 as observed in Tehran University.
Fazeli MS; Adel MG; Lebaschi AH
Dis Colon Rectum; 2007 Jul; 50(7):990-5. PubMed ID: 17525859
[TBL] [Abstract][Full Text] [Related]
8. Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome.
Van Lier MG; De Wilt JH; Wagemakers JJ; Dinjens WN; Damhuis RA; Wagner A; Kuipers EJ; Van Leerdam ME
Scand J Gastroenterol; 2009; 44(5):600-4. PubMed ID: 19153873
[TBL] [Abstract][Full Text] [Related]
9. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
[TBL] [Abstract][Full Text] [Related]
10. Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features.
Leopoldo S; Lorena B; Cinzia A; Gabriella DC; Angela Luciana B; Renato C; Antonio M; Carlo S; Cristina P; Stefano C; Maurizio T; Luigi R; Cesare B
Ann Surg Oncol; 2008 May; 15(5):1429-39. PubMed ID: 18301950
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas.
Hornick JL; Farraye FA; Odze RD
Am J Surg Pathol; 2007 Feb; 31(2):207-15. PubMed ID: 17255765
[TBL] [Abstract][Full Text] [Related]
12. Fas ligand is up-regulated during the colorectal adenoma-carcinoma sequence.
Belluco C; Esposito G; Bertorelle R; Alaggio R; Giacomelli L; Bianchi LC; Nitti D; Lise M
Eur J Surg Oncol; 2002 Mar; 28(2):120-5. PubMed ID: 11884046
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiological study, pathologic evaluation and prognostic factors of colorectal mucinous vs non-mucinous adenocarcinoma (a series of 196 patients)].
Arfaoui Toumi A; Kriaa Ben Mahmoud L; Khiari M; Lahmer A; Gharbi L; Dhraïef M; Khalfallah T; Regaya Mzabi S; Bouraoui S
Tunis Med; 2010 Jan; 88(1):12-7. PubMed ID: 20415207
[TBL] [Abstract][Full Text] [Related]
14. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
[TBL] [Abstract][Full Text] [Related]
15. Colorectal carcinoma in different age groups: a population-based investigation.
Fante R; Benatti P; di Gregorio C; De Pietri S; Pedroni M; Tamassia MG; Percesepe A; Rossi G; Losi L; Roncucci L; Ponz de Leon M
Am J Gastroenterol; 1997 Sep; 92(9):1505-9. PubMed ID: 9317073
[TBL] [Abstract][Full Text] [Related]
16. Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development.
Yamamichi N; Shimomura R; Inada K; Sakurai K; Haraguchi T; Ozaki Y; Fujita S; Mizutani T; Furukawa C; Fujishiro M; Ichinose M; Shiogama K; Tsutsumi Y; Omata M; Iba H
Clin Cancer Res; 2009 Jun; 15(12):4009-16. PubMed ID: 19509156
[TBL] [Abstract][Full Text] [Related]
17. Correlation of microsatellite status, proliferation, apoptotic and selected immunohistochemical markers in colorectal carcinoma studied with tissue microarray.
Okoń K; Demczuk S; Klimkowska A; Wójcik P; Osuch C; Papla B; Stachura J
Pol J Pathol; 2006; 57(2):105-11. PubMed ID: 17019973
[TBL] [Abstract][Full Text] [Related]
18. Deregulated expression of miR-106a predicts survival in human colon cancer patients.
Díaz R; Silva J; García JM; Lorenzo Y; García V; Peña C; Rodríguez R; Muñoz C; García F; Bonilla F; Domínguez G
Genes Chromosomes Cancer; 2008 Sep; 47(9):794-802. PubMed ID: 18521848
[TBL] [Abstract][Full Text] [Related]
19. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
20. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
Qian B; Katsaros D; Lu L; Preti M; Durando A; Arisio R; Mu L; Yu H
Breast Cancer Res Treat; 2009 Sep; 117(1):131-40. PubMed ID: 18932017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
